On Friday, Congress leader Priyanka Gandhi Vadra criticized the Modi government for purported irregularities in the NEET medical entrance exam, urging that students’ “valid complaints” be addressed through an investigation.
Several aspirants of the medical entrance exam NEET have alleged inflation of marks which led to a record 67 candidates bagging the top rank, including six from the same exam centre.
The National Testing Agency (NTA) refuted any allegations of irregularities, attributing the higher scores of students to alterations in the NCERT textbooks and the provision of grace marks for time lost at examination centers.
In a post in Hindi on X, Gandhi said, “First the NEET exam paper was leaked and now the students allege that there has been a scam in its results as well. Serious questions are being raised on 6 students of the same centre getting 720 out of 720 marks and many kinds of irregularities are coming to the fore.”
Gandhi mentioned that there are reports of numerous children taking their own lives nationwide following the announcement of the results, expressing deep sadness and shock over the matter.
She questioned why the government is disregarding the concerns of millions of students. Gandhi emphasized that students are seeking answers to valid questions regarding alleged manipulation in the NEET exam results.
Gandhi further inquired whether it is not the government’s duty to address these “legitimate complaints” by initiating an investigation.
Mark Zuckerberg's remark about India's 2024 elections, facing backlash from officials who emphasized the government’s…
Delhi Congress president Devender Yadav, accompanied by Jharkhand Minister for Panchayati Raj Dipika Pandey Singh,…
The relationship between gut microbes, hormones, and dietary preferences is a fascinating area of study…
AI systems like ChatGPT have been linked to environmental concerns, with reports showing their significant…
Rabi Lamichhane, RSP chief and ex-home minister, secures bail in the Swarnalakshmi Cooperative fraud case…
Metformin, the widely prescribed drug for managing type 2 diabetes, has recently gained attention for…